MiMedx Group, Inc (MDXG) vs OmniAb, Inc. (OABI)
MiMedx Group, Inc and OmniAb, Inc. are both Biotechnology companies. MiMedx Group, Inc and OmniAb, Inc. are of similar size ($697.9M and $686.5M). OmniAb, Inc. has negative trailing earnings, so its P/E is not meaningful; MiMedx Group, Inc trades at 117×. OmniAb, Inc. grew revenue faster over the last twelve months: 67.0% against −2.36%. MiMedx Group, Inc has the higher net margin (1.76% vs −115.1%) and the higher return on invested capital (5.62% vs −14.5%). Across the 17 metrics below, MiMedx Group, Inc leads on 13 and OmniAb, Inc. on 4.
Valuation
Profitability
| Metric | MDXG | OABI | Biotechnology median |
|---|---|---|---|
| Gross margin | 78.85% | 98.28% | 65.16% |
| Operating margin | 2.46% | (125.78%) | 0.00% |
| Net margin | 1.76% | (115.12%) | 0.00% |
| Free cash flow margin | 12.51% | (47.17%) | 0.00% |
| Return on equity | 2.88% | (16.95%) | (57.72%) |
| Return on assets | 2.18% | (15.11%) | (49.22%) |
| Return on invested capital | 5.62% | (14.52%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack